HKD9.66
1.63%
Hong Kong, Fri, Jun 13 2025
ISIN
BMG210A71016
Symbol
512
Sector
Industry

Grand Pharmaceutical Target price 2025 - Analyst rating & recommendation

Grand Pharmaceutical Classifications & Recommendation:

Buy
100%

Grand Pharmaceutical Price Target

Target Price HKD9.88
Price HKD9.66
Potential
Number of Estimates 2
2 Analysts have issued a price target Grand Pharmaceutical 2026 . The average Grand Pharmaceutical target price is HKD9.88. This is higher than the current stock price. The highest price target is , the lowest is .
A rating was issued by 4 analysts: 4 Analysts recommend Grand Pharmaceutical to buy, 0 to hold and 0 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Grand Pharmaceutical stock has an average upside potential 2026 of . Most analysts recommend the Grand Pharmaceutical stock at Purchase.

Sales and Margin forecast 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Revenue Billion HKD 11.64 12.42
10.59% 6.69%
EBITDA Margin 23.39% 23.99%
24.25% 2.58%
Net Margin 21.20% 16.91%
18.72% 20.22%

4 Analysts have issued a sales forecast Grand Pharmaceutical 2025 . The average Grand Pharmaceutical sales estimate is

HKD12.4b
Unlock
. This is
6.69% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
HKD12.7b 9.32%
Unlock
, the lowest is
HKD11.9b 2.22%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2024 HKD11.6b 10.59%
2025
HKD12.4b 6.69%
Unlock
2026
HKD13.6b 9.79%
Unlock
2027
HKD15.3b 12.33%
Unlock

1 Analyst has issued a net profit forecast Grand Pharmaceutical 2025 . The average Grand Pharmaceutical net profit estimate is

HKD2.1b
Unlock
. This is
14.88% lower
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
HKD2.1b 14.88%
Unlock
, the lowest is
HKD2.1b 14.88%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2024 HKD2.5b 31.30%
2025
HKD2.1b 14.88%
Unlock
2026
HKD2.2b 5.00%
Unlock

Net Margin

2024 21.20% 18.72%
2025
16.91% 20.22%
Unlock
2026
16.17% 4.38%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027

Create a premium account to unlock analyst estimates. Learn more

Dec '24 2025
Estimates
Earnings Per Share HKD 0.70 0.60
29.63% 14.29%
P/E 16.37
EV/Sales 2.78

1 Analysts have issued a Grand Pharmaceutical forecast for earnings per share. The average Grand Pharmaceutical EPS is

HKD0.60
Unlock
. This is
14.29% lower
Unlock
than earnings per share in the financial year 2024. The highest EPS forecast is
HKD0.60 14.29%
Unlock
, the lowest is
HKD0.60 14.29%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2024 HKD0.70 29.63%
2025
HKD0.60 14.29%
Unlock
2026
HKD0.63 5.00%
Unlock

P/E ratio

Current 14.03 55.55%
2025
16.37 16.69%
Unlock
2026
15.59 4.76%
Unlock

Based on analysts' sales estimates for 2025, the Grand Pharmaceutical stock is valued at an EV/Sales of

and an P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.96 71.10%
2025
2.78 6.19%
Unlock
2026
2.53 8.92%
Unlock
2027
2.25 10.98%
Unlock

P/S ratio

Current 2.82 71.75%
2025
2.64 6.27%
Unlock
2026
2.41 8.92%
Unlock
2027
2.14 10.98%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today